Freedom Furniture has paid penalties of $25,200 after being hit with two infringement notices by the Australian Competition and Consumer Commission for allegedly misleading customers about their consumer guarantee rights.
Westpac has become the latest company to discover it shortchanged workers, announcing it will pay $8 million to around 8,000 current and former staff who were not paid long service leave entitlements.
Law firms seeking to bring class actions on a contingency fee basis in the Victorian Supreme Court must seek court approval for the now-legal arrangement as early as possible in the proceeding, the court has said.
An external adviser will handle workplace misconduct claims against judges at the NSW Supreme Court under a new policy implemented following allegations that former High Court justice Dyson Heydon sexually harassed six female associates during his time on the bench.
Former High Court Justice Dyson Heydon can no longer practice as a barrister, after an investigation conducted by the court found he sexually harassed six female associates.
The company that operates the Newmarch House nursing home in Sydney is facing a possible class action after a coronavirus outbreak at the facility resulted in the deaths of 19 residents.
A judge has rejected new evidence sought to be advanced by Hytera Communications in its IP battle with Motorola that Motorola deliberately delayed notifying Hytera of possible theft of its source code because it wanted to improve its market position.
Shine Lawyers has been given the go ahead to use two reports produced in three settled PFAS class actions as evidence in its latest case over the Defence Department’s firefighting foam, with a judge saying any implied undertaking not to re-use the material lost force when the information became public.
Owners of units in Sydney’s Opal Tower have filed a lawsuit against the NSW Government and builder Icon after allegedly discovering more than 500 additional defects in the troubled building.
Drug maker Janssen has fired off a lawsuit against Juno Pharmaceuticals for allegedly threatening to infringe a patent for its HIV drug Prezista with a generic version of the drug, one year after fending off generic competition from a different drug maker.